Last update :
05/12/2025
Anticoagulant   Enoxaparin sodium  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Bolentax Mexico
Clasina Colombia
Clasina Colombia, Ecuador, Peru
Clexan Greece
Clexane Argentina, Australia, Belgium, Brazil, Chile, Colombia, Ecuador, Egypt, Germany, Great Britain, Iran, Ireland, Italy, Japan, Luxembourg, Malaysia, Mexico, Netherlands, New Zealand, Peru, Poland, Romania, Saudi Arabia, Spain, Switzerland, Turkey, United Arab Emirates, Venezuela
Cutenox Brazil, Peru
Dilutol Argentina, Ecuador, Spain
Dynalin India
Enoparin Venezuela
Enoxalon Chile
Enoxanorth Argentina
Enoxatal Colombia
Hemofagin Chile
Inhixa Germany
Klexane Denmark, Finland, Germany, Norway, Sweden
Lovenox Austria, Canada, France, Germany, Morocco, Portugal, Tunisia, United States of America
Lowparin Egypt
Nurox Chile, Colombia, Ecuador
References   injection   References : Enoxaparin sodium  
Type Publication
311 Journal Newborn AL, Kessler JM, Joyner KA.
Compatibility and activity of enoxaparin sodium in 0.9% sodium chloride injection for 48 hours.
Am J Health-Syst Pharm 1996 ; 53: 167-169.
811 Journal Charland SL, Davis DD, Tillman DJ.
Activity of enoxaparin sodium in tuberculin syringes for 10 days.
Am J Health-Syst Pharm 1998 ; 55: 1296-1298.
1893 Journal Dager WE, Gosselin RC, King JF, Christensen CL, Owings JT, Larkin EC.
Anti-Xa stability of diluted enoxaparin for use in pediatrics.
Ann Pharmacotherapy 2004 ; 38: 569-573.
2231 Journal de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3643 Manufacturer Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
4413 Journal Moffett B.S, Dinh K, Placencia J, Pelkey G, Rocky Hui S-K, Teruya J.
Stability and Sterility of Enoxaparin 8 mg/mL Subcutaneous Injectable Solution.
J Pediatr Pharmacol Ther 2016 ; 21, 4: 322-326.
4985 Manufacturer ENOXAPARINE ARROW 10 000 UI (100 mg)/1 mL, solution injectable en seringue préremplie - Résumé des caractéristiques du produit.
ARROW GENERIQUES 2023

  Mentions Légales